Abstract:Myocardial ischemia is a leading cause of death all over the world. The most effective way to salvage ischemic myocardium is the restoration of blood flow, but reperfusion itself may cause additional tissue injury called “ischemia/reperfusion injury (I/RI)”. Activation of cell apoptosis is a major form of cell death during myocardial I/RI. Thus, examining ways to control cell apoptosis has important clinical significance for improving post‐ischemic recovery. MicroRNAs (miR), small non‐coding RNA molecules that regulate gene expression by inhibiting mRNA translation and/or inducing mRNA degradation, play a crucial role in various cellular and biological processes. The clinical evidence demonstrated that miR‐181c was significantly up‐regulated in the early phase of myocardial infarction. However, whether or not miR‐181c mediates cardiac I/RI through cell apoptosis pathway is unknown. Thus, the present study aimed to investigate the role of miR‐181c in hypoxia/reoxygenation (H/R, 6 hours hypoxia followed by6 hours reoxygenation) induced cell injury in H9C2 cardiomyocytes and its possible mechanism. The results showed that H/R significantly increased the expression of miR‐181c‐5p (P<0.05 vs. Control) but not miR‐181c‐3p in H9C2 cells. In line with this, in an in vivo rat cardiac I/RI model (30 min left anterior descending coronary artery ligation followed by 2 hours reperfusion), miR‐181c‐5p expression was also significantly increased (P<0.05 vs. Control), suggesting that miR‐181c‐5p may be involved in the pathogenesis of cardiac I/RI. Under the experimental setting, H/R significantly induced H9C2 cells injury, as evidenced by increased lactic acid dehydrogenase (LDH) leakage (cell injury marker, P<0.05 vs. Control) and reduced cell viability (MTT assay, P<0.05 vs. Control). Furthermore, H/R‐induced cell injury was accompanied by increased cleaved caspase‐3 expression and more TUNEL positive cells (markers of cell apoptosis, P<0.05 vs. Control), but no significant changes in the expression of Bcl‐2 (anti‐apoptotic) and Bax (pro‐apoptotic), suggesting that H/R induces caspase‐3 dependent cell apoptosis, which was independent of the intrinsic mitochondrial pathway. To demonstrate the potential role of miR‐181c‐5p in H/R‐induced cell injury, H9C2 cells were transfected with the miR‐181c‐5pagomir or its negative control. The overexpression of miR‐181c‐5psignificantly aggravated H/R‐induced cell injury (increased LDH level and reduced cell viability, P<0.05 vs.H/R) and exacerbated H/R‐induced cell apoptosis (greater cleaved caspases‐3 expression and more TUNEL positive cells, P<0.05 vs.H/R). In contrast, in H9C2 cells transfected with miR‐181c‐5p antagomir, inhibition of miR‐181c‐5p significantly suppressed H/R‐induced enhancement of LDH level and cleaved caspase‐3 expression and apoptotic cell death(P<0.05 vs.H/R). It is concluded that in H9C2 cells, H/R may induce cardiomyocytes apoptosis via enhanced miR‐181c‐5p expression, which may yield novel strategies to combat myocardial I/RI.Support or Funding InformationThe authors' research was supported by General Research Fund (17158616M and 17124614M, Research Grants Council of Hong Kong).This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Long Non-Coding RNA ROR Sponges Mir-138 to Aggravate Hypoxia/reoxygenation-Induced Cardiomyocyte Apoptosis Via Upregulating Mst1

Long Noncoding RNA AK123483 is Involved in the Regulation of Myocardial Ischaemia-Reperfusion Injury by Targeting PARP and Caspase-3

LncRNA ROR modulates myocardial ischemia-reperfusion injury mediated by the miR-185-5p/CDK6 axis

LncRNA LOC100360491 overexpression inhibits hypoxia-reoxygenation-induced apoptosis of H9c2 cells by upregulating PAK3 transcription

Overexpression of Long noncoding RNA Oprm1 Attenuates Myocardial Ischemia/Reperfusion Injury by Increasing Endogenous Hydrogen Sulfide Production via Oprm1/miR-30b-5p/CSE axis

LncRNA Oprm1 Overexpression Attenuates Myocardial Ischemia/reperfusion Injury by Increasing Endogenous Hydrogen Sulfide Via Oprm1/miR-30b-5p/CSE Axis

The lncRNA ROR/miR-124-3p/TRAF6 axis regulated the ischaemia reperfusion injury-induced inflammatory response in human cardiac myocytes

LncRNA RNA ROR Aggravates Hypoxia/Reoxygenation-Induced Cardiomyocyte Ferroptosis by Targeting miR-769-5p/CBX7 Axis

Deficiency of a novel lncRNA-HRAT protects against myocardial ischemia reperfusion injury by targeting miR-370-3p/RNF41 pathway

Knockdown of Lncrna SNHG16 Attenuates Myocardial Ischemia‑reoxygenation Injury Via Targeting Mir‑183/foxo1 Axis.

Long Noncoding RNA NEAT1 Promotes Myocardiocyte Apoptosis and Suppresses Proliferation Through Regulation of miR-129-5p

MiR-138 Ameliorates Myocardial Ischemia/reperfusion Injury by Targeting Intercellular Cell Adhesion Molecule 1

LncRNA 93358 Aggravates the Apoptosis of Myocardial Cells After Ischemia‐Reperfusion by Mediating the PI3K/AKT/mTOR Pathway

MicroRNA‐181c‐5p Exacerbates Apoptotic Cell Death in H9C2 Cardiomyocytes During Hypoxia/reoxygenation

lncRNA Nuclear Factor of Activated T Cells Knockdown Alleviates Hypoxia/Reoxygenation-induced Cardiomyocyte Apoptosis by Upregulating HIF-1α Expression

LncRNA SNHG1 alleviates myocardial ischaemia–reperfusion injury by regulating the miR‐137‐3p/KLF4/TRPV1 axis

MiR-138-5p exacerbates hypoxia/reperfusion-induced heart injury through the inactivation of SIRT1-PGC-1α

lncRNA Oip5-as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR-29a to activate the SIRT1/AMPK/PGC1α pathway.

Mir-181C-5p Exacerbates Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis Via Targeting PTPN4

LncRNA SNHG1 alleviates hypoxia-reoxygenation-induced vascular endothelial cell injury as a competing endogenous RNA through the HIF-1α/VEGF signal pathway

The Long Non-Coding RNA TUG1-miR-9a-5p Axis Contributes to Ischemic Injuries by Promoting Cardiomyocyte Apoptosis Via Targeting KLF5